Cysteine protease inhibitors

Details for Australian Patent Application No. 2005203972 (hide)

Owner Medivir AB

Inventors Kangasmetsa, Jussi; Diaz, Victor; Grabowska, Urszula; Noren, Rolf; Nilsson, Magnus; Liley, Mark; Crespo, Laia; Jackson, Philip; Classon, Bjorn; Tozer, Matt; Oden, Lourdes; Fallon, Philip; Bonnaud, Thierry; Johnson, Tony; Zhou, Xiao-Xiong; Carr, Andrew

Agent Davies Collison Cave

Pub. Number AU-B-2005203972

PCT Pub. Number WO2005/066180

Priority 0401332-2 26.05.04 SE; 0400022-0 08.01.04 SE

Filing date 6 January 2005

Wipo publication date 21 July 2005

Acceptance publication date 18 November 2010

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/066180 Priority application(s): WO2005/066180

18 November 2010 Application Accepted

  Published as AU-B-2005203972

17 March 2011 Standard Patent Sealed

2 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005203988-Hyaluronic acid derivative and drug containing the same

2005203962-Interleukin-12 targeted to oncofoetal fibronectin